By targeting three key growth pathways at once, researchers eliminated pancreatic tumors in multiple mouse models and ...

New research suggests THC’s cognitive drawbacks may be mitigated when combined with a targeted anti-inflammatory drug. Cannabis research has highlighted a scientific paradox. Its best-known ...

A new umbrella review reveals how GLP-1 therapies shape cardiovascular, renal, and metabolic outcomes in type 2 diabetes while highlighting drug-specific advantages and the need to manage ...

Depression is one of the most widespread mental health disorders worldwide, affecting approximately 4% of the global ...

The Law of Mass action predicts that all adverse drug reactions are related to the concentration of the drug at the site of ...

A new study on a drug widely prescribed for asthma is binding itself to receptors in the brain and is linked to severe mental health issues and suicide, according to new research. The Food and Drug ...

Scientists think they may have developed a new weight loss drug that is more than twice as effective as Ozempic with fewer negative side effects. GLP-1 injectable medications, which include Ozempic, ...

The US Food and Drug Administration (FDA) has cleared Novaliq’s Investigational New Drug (IND) application for NOV05, enabling the initiation of the EYETAC phase II clinical trial ( NCT07285070) in ...

Eye-stroke, vomiting and burst colon: Lawsuits accuse weight-loss drugs of severe side effects - Thousands of patients have ...

A new study on asthma medication Singulair has raised concerns about its potential mental health side effects, USA Today reported Nov. 24. The study, presented by the FDA at the American College of ...

A popular drug for dogs with arthritis may be associated with a variety of potentially severe neurological effects, including seizures and a loss of muscle control, according to a recent review by the ...